M&G Investments
The rounds this investor is named on, who it invests beside, and where it shows up.
The rounds this investor is named on, who it invests beside, and where it shows up.
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Series D Verified against 4 of 9 sources | $25M | 2026-11-04 | [ PART ] |
Nearfield Instruments Nearfield Instruments provides innovative metrology solutions for process control challenges in the high-end nano-electronics industry, focusing on atomic force microscopy systems. | Series D |
| $380M |
| 2026-06-22 |
| [ PART ] |
PhysicsX A physics AI company for industrials | Series C Verified against 1 of 6 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $300M | 2026-06-08 | [ PART ] |
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2026-01-09 | [ LEAD ] |
Mainspring Energy Mainspring Energy sells linear generators for flexible, low-emissions power solutions to businesses across various industries. | Series F Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $258M | 2025-04-14 | [ PART ] |
AMBOSS AMBOSS: The digital medical resource that supports physicians in the hospital and students in the classroom. | Funding round Verified against 1 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $259.8M | 2025-03-25 | [ LEAD ] |
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2024-12-16 | [ LEAD ] |
Nearfield Instruments Nearfield Instruments provides innovative metrology solutions for process control challenges in the high-end nano-electronics industry, focusing on atomic force microscopy systems. | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $147.6M | 2024-07-18 | [ PART ] |